The goal of ARPA-H's EHI Initiative is to foster innovation that improves health for all. Whether you’re an early-career investigator or a community-based innovator, there’s a place for you to create change!

I’m amazed by and thankful for my colleagues at ARPA-H. There’s no other team I’d rather work with to accelerate health outcomes for all, and this year in particular, work with to addresses critical unmet challenges in women’s health. Happy Thanksgiving!

DYK ARPA-H uses diverse funding mechanisms including contracts and other transactions? These allow us to address the critical health challenges that traditional research and private industry cannot. #SmallBusinessSaturday arpa-h.gov/engage-and-tra…

Improving clinical trials will take collaboration from experts across the country. Through the integration of leading-edge technology, diverse expertise, and the power of ARPANET-H Health Innovation Network, we’re poised to transform how we bring new health solutions to patients.

THEA intends to revolutionize the reconnection of nerves to the brain and develop breakthroughs in transplantation, preservation, and neuroscience. ARPA-H's investment has the potential to repair vision loss for millions of Americans!

Incredible to see the cover of Science Magazine featuring work partly supported by ARPA-H's CT-NEURO project, a cellular therapeutic platform that could support better treatments/outcomes for brain tumors like glioblastoma, chronic disorders like multiple sclerosis & Alzheimer’s

Our team is heading to the #JPM2025! Don’t miss the chance to meet us in San Francisco and discuss how to accelerate projects and navigate the path from concept to commercialization. Express your interest by December 20. hubs.ly/Q02-MTkT0

So nice to see ARPA-H's REO project, which aims to create two unique oral therapeutics to treat metabolic diseases including diabetes and obesity, acknowledged in the nature portfolio. nature.com/articles/s4158…

Dr. Amy Jenkins, our Health Science Futures Mission Office Director, said it best, “ARPA-H is boldly investing in this novel research area because we envision a future where cancers are treated more quickly and easily.”

PROSPR represents a tectonic shift in the study of healthy aging. The program’s aim is to identify physiological and biochemical markers of early health changes during aging and to develop therapeutics aimed at prolonging healthspan for all Americans!

RAPID represents a paradigm shift in how we approach rare disease diagnosis, with the potential to transform the difficult journey experienced by many rare disease patients. Timely, accurate diagnoses can lead to better outcomes for millions navigating these complex conditions.

TODAY: We are ringing in more than just the New Year! 🎊 Join ARPA-H and #SprintForWomensHealth awardees as we ring Nasdaq’s first closing bell of 2025! 🥂 Watch the livestream at 3:45 pm-4:15 pm ET: nasdaq.com/events/dare-bi…

We're starting the year with purpose & momentum, by ringing the Nasdaq closing bell. Our message, alongside trailblazers like Sabrina Johnson & her team Daré Bioscience, Inc. & other ARPA-H performers, is simple yet powerful: "Dare to Invest in Women's Health." nasdaq.com/events/dare-bi…

Excited to be part of #JPM25 this week! 2025 is going to be a bright year for medtech/biotech and ARPA-H, and the team is excited to engage the ecosystem this week - let's connect!

Every year, millions of American families bear the overwhelming costs of brain damage. FRONT is set to change the future of brain repair, providing not only groundbreaking solutions for patients but also driving economic benefits for the nation.

Congratulations to Dr. Susan Monarez on her milestone appointment to CDC Director! Dr. Monarez previously served as our Deputy Director and will now lead CDC's efforts to prevent disease and respond to domestic and global health threats.

Had the pleasure of attending the “Make Health Tech Great Again” event hosted with CMSGov at the The White House. This movement aims to help build the next-generation of the patient-centered digital health ecosystem.

Congrats! The success of the #AlxCC finalists shows the real-world potential of Al to address vulnerabilities in our health care system. ARPA-H is committed to supporting teams to transition their technologies and make an impact in health care security and patient safety.